Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Man Killed in Crash at Union Avenue and 2nd Street


Victim Hit by Truck in Fatal Bakersfield Accident 

Pedestrian Fatality 2

Bakersfield, CA (March 9, 2020) – A man was killed in a pedestrian crash in Bakersfield. The fatal accident occurred on the morning of March 9 at Union Avenue and 2nd Street.

A woman was driving a truck when she hit a man walking near the intersection. The man died from his injuries. The woman remained at the accident scene. 

Our heartfelt condolences go out to the friends and loved ones of the victim.

 #Bakersfield

#93307


November 21, 2019

1 Injured in Crash on Highway 65 Near Avenue 184

Big Rig Involved in Porterville Accident...


April 9, 2020

Motorcyclist Injured in Crash at Main Avenue and Greenback Lane

Motorcycle, Pickup Truck Collide in Orangevale Accident...


January 27, 2020

Man Killed in Hit and Run Crash on Fair Oaks Boulevard

Victim Was Intoxicated at Time of Fatal Fair Oaks Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.